Filing Details
- Accession Number:
- 0001209191-17-059988
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-09 16:43:19
- Reporting Period:
- 2017-11-08
- Accepted Time:
- 2017-11-09 16:43:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107421 | Ziopharm Oncology Inc | ZIOP | Pharmaceutical Preparations (2834) | 841475642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1641506 | Neil James Laurence Cooper | C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg. 34 Boston MA 02129 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-08 | 6,440 | $4.68 | 1,083,731 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.71, inclusive.The Reporting Person undertakes to provide to the Issuer, any stockholder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
